Fungal siderophores function as protective agents of LDL oxidation and are promising anti-atherosclerotic metabolites in functional food

Molecular Nutrition and Food Research

Volumn 52, Issue 12, 2008, Pages 1434-1447

  Pócsi, István ^a   Jeney, Viktória ^b   Kertai, Pál ^b   Pócsi, Imre ^a   Emri, Tamás ^a   Gyémánt, Gyöngyi ^a   Fésüs, László ^b   Balla, József ^b,c   Balla, György ^b  

^a UNIVERSITY OF DEBRECEN   (Hungary)

^b UNIVERSITY OF DEBRECEN   (Hungary)

^c UNIVERSITY OF DEBRECEN   (Hungary)

Author keywords

Atherosclerosis; Functional food; Heme oxygenase; LDL oxidation; Siderophores

Indexed keywords

COPROGEN; DESFERRICOPROGEN; HEME OXYGENASE 1; HYDROXAMIC ACID; IRON CHELATING AGENT; LOW DENSITY LIPOPROTEIN; OXIDIZED LOW DENSITY LIPOPROTEIN; PIPERAZINEDIONE; PROTECTIVE AGENT; SIDEROPHORE;

ANIMAL; ARTICLE; ATHEROSCLEROSIS; DOSE RESPONSE; DRUG EFFECT; GENETICS; HUMAN; LIPID PEROXIDATION; LIVER; METABOLISM; RAT;

ANIMALS; ATHEROSCLEROSIS; DIKETOPIPERAZINES; DOSE-RESPONSE RELATIONSHIP, DRUG; HEME OXYGENASE-1; HUMANS; HYDROXAMIC ACIDS; IRON CHELATING AGENTS; LIPID PEROXIDATION; LIPOPROTEINS, LDL; LIVER; PROTECTIVE AGENTS; RATS; SIDEROPHORES;

RATTUS;

EID: 57549101712     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.200700467     Document Type: Article

References (78)

1. Halliwell, B., Gutteridge, J. M., Cross, C. E., Free radicals, antioxidants, and human disease: where are we now? J. Lab. Clin. Med. 1992, 119, 598-620.
2. Tegos, T. J., Kalodiki, E., Sabetai, M. M., Nicolaides, A. N., The genesis of atherosclerosis and risk factors: A review. Angiology 2001, 52, 89-98.
3. Kim, S., Ponka, P., Effects of interferon-gamma and lipopolysaccharide on macrophage iron metabolism are mediated by nitric oxide-induced degradation of iron regulatory protein 2. J. Biol. Chem. 2000, 275, 6220-6226.
4. Fleming, D. J., Jacques, P. F., Tucker, K. L., Massaro, J. M., et al., Iron status of the free-living, elderly Framingham Heart Study cohort: An iron-replete population with a high prevalence of elevated iron stores. Am. J. Clin. Nutr. 2001, 73, 638-646.
5. Weiss, G., Iron and immunity: A double-edged sword. Eur. J. Clin. Invest. 2002, 32, 70-78.
6. Sullivan, J. L., The iron paradigm of ischemic heart disease. Am. Heart J. 1989, 117, 1177-1188.
7. Salonen, J. T., Korpela, H., Nyyssonen, K., Porkkala, E., et al., Lowering of body iron stores by blood letting and oxidation resistance of serum lipoproteins: A randomized cross-over trial in male smokers. J. Intern. Med. 1995, 237, 161-168.
8. Ponka, P., Beaumont, C., Richardson, D. R., Function and regulation of transferrin and ferritin. Semin Hematol. 1998, 35, 35-54.
9. Danesh, J., Appleby, P., Coronary heart disease and iron status: Meta-analyses of prospective studies. Circulation 1999, 99, 852-854.
10. Rossi, E., McQuillan, B. M., Hung, J., Thompson, P. L., et al., Serum ferritin and C282Y mutation of the hemochromatosis gene as predictors of asymptomatic carotid atherosclerosis in a community population. Stroke 2000, 31, 3015-3020.
11. Hunter, G. C., Dubick, M. A., Keen, C. L., Eskelson, C. D., Effects of hypertension on aortic antioxidant status in human abdominal aneurysmal and occlusive disease. Proc. Soc. Exp. Biol. Med. 1991, 196, 273-279.
12. Smith, C., Mitchinson, M. J., Aruoma, O. I., Halliwell, B., Stimulation of lipid peroxidation and hydroxyl-radical generation by the contents of human atherosclerotic lesions. Biochem. J. 1992, 286, 901-905.
13. Juckett, M. B., Balla, J., Balla, G., Jessurun, J., et al., Ferritin protects endothelial cells from oxidized low density lipoprotein in vitro. Am. J. Pathol. 1995, 147, 782-789.
14. Wang, L., Lee, T., Lee, F., Pai, R., Chau, L., Expression of heme oxygenase-1 in atherosclerotic lesions. Am. J. Pathol. 1998, 152, 711-720.
15. Balla, J., Vercellotti, G. M., Jeney, V., Yachie, A., et al., Heme, heme oxygenase and ferritin in vascular endothelial injury. Mol. Nutr. Food Res. 2005, 49, 1030-1043.
16. Balla, J., Vercellotti, G. M., Jeney, V., Yachie, A., et al., Heme, Heme oxygenase, and ferritin: How the vascular endothelium survives and dies in an iron-rich environment. Antiox. Redox. Signal. 2007, 9, 2119-2138.
17. Varani, J., Fligiel, S. E., Till, G. O., Kunkel, R. G., et al., Pulmonary endothelial cell killing by human neutrophils. Possible involvement of hydroxyl radical. Lab. Invest. 1985, 53, 656-663.
18. Lentsch, A. B., Ward, P. A., Regulation of inflammatory vascular damage. J. Pathol. 2000, 190, 343-348.
19. Halliwell, B., Protection against tissue damage in vivo by desferrioxamine: What is its mechanism of action? Free Radic. Biol. Med. 1989, 7, 645-651.
20. Hershko, C., Pinson, A., Link, G., Iron chelation. Blood Rev. 1990, 4, 1-8.
21. Hershko, C., Konijn, A. M., Link, G., Iron chelators for thalassaemia. Br. J. Haematol. 1998, 101, 399-406.
22. Duffy, S. J., Biegelsen, E. S., Holbrook, M., Russell, J. D., et al., Iron chelation improves endothelial function in patients with coronary artery disease. Circulation 2001, 103, 2799-2804.
23. Drechsel, H., Winkelmann, G., in: Winkelmann, G., Carrano, C. J. (Eds.), Transition Metals in Microbial Metabolism, Harwood Academic Publishers, Amsterdam 1997, pp. 1-49.
24. Albrecht-Gary, A. M., Crumbliss, A. L., in: Sigel, A., Sigel, H. (Eds.), Metal Ions in Biological Systems Vol. 35: Iron Transport and Storage in Microorganisms, Plants, and Animals, Marcel Dekker, New York 1998, pp. 239-326.
25. Crichton, R. R., Pierre, J. L., Old iron, young copper: From Mars to Venus. Biometals 2001, 14, 99-112.
26. Britigan, B. E., Rasmussen, G. T., Cox, C. D., Augmentation of oxidant injury to human pulmonary epithelial cells by the Pseudomonas aeruginosa siderophore pyochelin. Infect. Immun. 1997, 65, 1071-1076.
27. DeWitte, J. J., Cox, C. D., Rasmussen, G. T., Britigan, B. E., Assessment of structural features of the pseudomonas siderophore pyochelin required for its ability to promote oxidant-mediated endothelial cell injury. Arch. Biochem. Biophys. 2001, 393, 236-244.
28. Howard, D. H., Acquisition, transport, and storage of iron by pathogenic fungi. Clin. Microbiol. Rev. 1999, 12, 394-404.
29. Ong, S. A., Neilands, J. B., Siderophores in microbially processed cheese. J. Agric. Food Chem. 1979, 27, 990-995.
30. Wen, Y., Leake, D. S., Low density lipoprotein undergoes oxidation within lysosomes in cells. Circ. Res. 2007, 100, 1337-1343.
31. Balla, G., Vercellotti, G. M., Eaton, J. W., Jacob, H. S., Iron loading of endothelial cells augments oxidant damage. J. Lab. Clin. Med. 1990, 116, 546-554.
32. Jeney, V., Balla, J., Yachie, A., Varga, Z., et al., Prooxidant and cytotoxic effects of circulating heme. Blood 2002, 100, 879-887.
33. Balla, G., Vercelotti, G. M., Muller-Eberhard, U., Eaton, J. W., Jacob, H. S., Exposure of endothelial cells to free heme potentiates damage mediated by granulocytes and toxic oxygen species. Lab. Invest. 1991, 64, 648-655.
34. Balla, G., Jacob, H. S., Eaton, J. W., Belcher, J. D., Vercelotti, G. M., Hemin: A possible physiological mediator of low density lipoprotein oxidation and endothelial injury. Arterioscler. Thromb. 1991, 11, 1700-1711.
35. Maines, M. D., Kappas, A., Cobalt induction of hepatic heme oxygenase; with evidence that cytochrome P-450 is not essential for this enzyme activity. Proc. Natl. Acad. Sci. USA 1974, 71, 4293-4297.
36. Shibahara, S., Yoshida, T., Kikuchi, G., Induction of heme oxygenase by hemin in cultured pig alveolar macrophages. Arch. Biochem. Biophys. 1978, 188, 243-250.
37. Abraham, N. G., Mitrione, S. M., Hodgson, W. J., Levere, R. D., Shibahara, S., Expression of heme oxygenase in hemopoiesis. Adv. Exp. Med. Biol. 1988, 241, 97-116.
38. Balla, G., Jacob, H. S., Balla, J., Rosenberg, M., et al., Ferritin: A cytoprotective antioxidant strategem of endothelium. J. Biol. Chem. 1992, 267, 18148-18153.
39. Keyse, S. M., Tyrell, R. M., Heme oxygenase is the major 32-kDa stress protein induced in human skin fibroblasts by UVA radiation, hydrogen peroxide, and sodium arsenite. Proc. Natl. Acad. Sci. USA 1989, 86, 99-103.
40. Agarwal, A., Balla, J., Balla, G., Croatt, A. J., et al., Renal tubular epithelial cells mimic endothelial cells upon exposure to oxidized LDL. Am. J. Physiol. 1996, 271, 814-823.
41. Balla, J., Balla, G., Jeney, V., Kakuk, G., et al., Ferriporphyrins and endothelium: a 2-edged sword-promotion of oxidation and induction of cytoprotectants. Blood 2000, 95, 3442-3450.
42. Tenhunen, R., Marver, H. S., Schmid, R., The enzymatic conversion of heme to bilirubin by microsomal heme oxygenase. Proc. Natl. Acad. Sci. USA 1968, 61, 748-755.
43. Yachie, A., Niida, Y., Wada, T., Igarashi, N., et al., Oxidative stress causes enhanced endothelial cell injury in human heme oxygenase-1 deficiency. J. Clin. Invest. 1999, 103, 129-135.
44. Kawashima, A., Oda, Y., Yachie, A., Koizumi, S., Nakanishi, I., Heme oxygenase-1 deficiency: The first autopsy case. Hum. Pathol. 2002, 33, 125-130.
45. Charlang, G., Ng, B., Horowitz, N. H., Horowitz, R. M., Cellular and extracellular siderophores of Aspergillus nidulans and Penicillium chrysogenum. Mol. Cell. Biol. 1981, 1, 94-100.
46. Jalal, M. A. F., Mocharla, R., Barnes, C. L., Hossain, M. B., et al., Extracellular siderophores from Aspergillus ochraceous. J. Bacteriol. 1984, 158, 683-688.
47. 3+ and in low-iron culture medium. Folia Microbiol. 2001, 46, 127-132.
48. Jalal, M. A. F., van der Helm, D., in: Winkelmann, G. (Ed.), CRC Handbook of Microbial Iron Chelators, CRC Press, Boca Raton 1991, pp. 235-269.
49. Heymann, P., Ernst, J. F., Winkelmann, G., Identification of a fungal triacetylfusarinine C siderophore transport gene (TAF1) in Saccharomyces cerevisiae as a member of the major facilitator superfamily. Biometals 1999, 12, 301-306.
50. Hördt, W., Römheld, V., Winkelmann, G., Fusarinines and dimerum acid, mono- and dihydroxamate siderophores from Penicillium chrysogenum, improve iron utilization by strategy I and strategy II plants. Biometals 2000, 13, 37-46.
51. Wong, G. B., Kappel, M. J., Raymond, K. N., Matzanke, B., Winkelmann, G., Coordination chemistry of microbial iron transport compounds. 24. Characterization of coprogen and ferricrocin, two ferric hydroxamate siderophores. J. Am. Chem. Soc. 1983, 105, 810-815.
52. Winkelmann, G., in: Barton, L. L., Hemming, B. C. (Eds.), Iron Chelation in Plants and Soil Organisms, Academic Press, San Diego 1993, pp. 219-239.
53. Belcher, J. D., Balla, J., Balla, G., Jacobs, D. R., et al., Vitamin E, LDL, and endothelium. Brief oral vitamin supplementation prevents oxidized LDL-mediated vascular injury in vitro. Arterioscler. Thromb. 1993, 13, 1779-1789.
54. Újhelyi, L., Balla, J., Muszbek, L., Kakuk, G., et al., A microassay to assess the oxidative resistance of low-density lipoproteins. Clin. Chem. 1998, 44, 1762-1764.
55. Balla, J., Jacob, H. S., Balla, G., Nath, K., et al., Endothelial-cell heme uptake from heme proteins: induction of sensitization and desensitization to oxidant damage. Proc. Natl. Acad. Sci. USA 1993, 90, 9285-9289.
56. Minqin, R., Watt, F., Huat, B. T., Halliwell, B., Correlation of iron and zinc levels with lesion depth in newly formed atherosclerotic lesions. Free Radic. Biol. Med. 2003, 34, 746-752.
57. Minqin, R., Rajendran, R., Pan, N., Tan, B. K. H., et al., The iron chelator desferrioxamine inhibits atherosclerotic lesion development and decreases lesion iron concentrations in cholesterol-fed rabbit. Free Radic. Biol. Med. 2005, 38, 1206-1211.
58. Balla, J., Vercellotti, G. M., Jeney, V., Yachie, A., et al., Heme, heme oxygenase and ferritin in vascular endothelial cell injury. Mol. Nutr. Food Res. 2005, 49, 1030-1043.
59. Li, W., Yuan, X. M., Brunk, U. T., OxLDL-induced macrophage cytotoxicity is mediated by lysosomal rupture and modified by intralysosomal redox-active iron. Free Radic. Res. 1998, 5, 389-398.
60. Dionis, J. B., Jenny, H. B., Peter, H. H., in: Winkelmann, G. (Ed.), CRC Handbook of Microbial Iron Chelators, CRC Press, Boca Raton 1991, pp. 339-356.
61. Ceci, A., Felisim, M., De Sanctism, V., De Mattia, D., Pharmacotherapy of iron overload in thalassaemic patients. Exp. Opin. Pharmacother. 2003, 4, 1763-1774.
62. Camejo, G., Halberg, C., Manschik-Lundin, A., Hurt-Camejo, E. et al., Hemin binding and oxidation of lipoproteins in serum: Mechanisms and effect on the interaction of LDL with human macrophages. J. Lipid Res. 1998, 39, 755-766.
63. Tribble, D. L., Krauss, R. M., Lansberg, M. G., Thiel, P. M., van den Berg, J. J., Greater oxidative susceptibility of the surface monolayer in small dense LDL may contribute to differences in copper-induced oxidation among LDL density subfractions. J. Lipid Res. 1995, 36, 662-671.
64. Yuan, X. M., Brunk, U. T., Olsson, A. G., Effects of iron- and hemoglobin-loaded human monocyte-derived macrophages on oxidation and uptake of LDL. Arterioscler. Thromb. Vasc. Biol. 1995, 9, 1345-1351.
65. Lapenna, D., Pierdomenico, S. D., Ciofani, G., Ucchino, S., et al., Association of body iron stores with low molecular weight iron and oxidant damage of human atherosclerotic plaques. Free Radic. Biol. Med. 2007, 42, 492-498.
66. Turbino-Ribeiro, S. M. L., Silva, M. E., Chianca, D. A., Jr., de Paula, H., et al., Iron overload in hypercholesterolemic rats affects iron homeostasis and serum lipids but not blood pressure. J. Nutr. 2003, 133, 15-20.
67. Engberink, M. F., Geleijnse, J. M., Durga, J., Swinkels, D. W. et al., Blood donation, body iron status and carotid intima-media thickness. Atherosclerosis 2008, 196, 856-862.
68. Zheng, H., Cable, R., Spencer, B., Votto, N., Katz, S. D., Iron stores and vascular function in voluntary blood donors. Arterioscler. Thromb. Vasc. Biol. 2005, 25, 1577-1583.
69. Vergnaud, A. C., Bertrais, S., Zureik, M., Galan, P., et al., Dietary iron uptake and serum ferritin in relation to 7.5 years structure and function of large arteries in the SUVIMAX cohort. Diabetes Metab. 2007, 5, 366-371.
70. Zacharski, L. R., Chow, B. K., Howes, P. S., Shamayeva, G., et al., Reduction of iron stores and cardiovascular outcomes in patients with peripheral arterial disease: A randomized controlled trial. JAMA 2007, 297, 603-610.
71. Burt, W. R., Identification of coprogen B and its breakdown products from Histoplasma capsulatum. Infect. Immun. 1982, 35, 990-996.
72. Hider, R. C., Choudhury, R., Rai, B. L., Dehkordi, L.S., Singh, S., Design of orally active iron chelators. Acta Haematol. 1996, 95, 6-12.
73. Porter, J. B., Evaluation of new iron chelators for clinical use. Acta Haematol. 1996, 95, 13-25.
74. Faa, G., Crisponi, G., Iron chelating agents in clinical practice. Coord. Chem. Rev. 1999, 184, 291-310.
75. Farkas, E., Csóka, H., Micera, G., Dessi, J., Copper(II), nickel(II), zinc(II), and molybdenum(VI) complexes of desferrioxamine B in aqueous solution. J. Inorg. Biochem. 1997, 65, 281-286.
76. Diamond, J. M., Wright, E. M., Biological membranes: The physical basis of ion and nonelectrolyte selectivity. Annu. Rev. Physiol. 1969, 31, 581-646.
77. Enyedy, É., Pócsi, I., Farkas, E., Complexation of desferricoprogen with trivalent Fe, Al, Ga, In and divalent Fe, Ni, Cu, Zn metal ions: Effects of the linking chain structure on the metal binding ability of hydroxamate based siderophores. J. Inorg. Biochem. 2004, 98, 1957-1966.
78. Grady, R. W., Graziano, J. H., Akers, H. A., Cerami, A., The development of new iron-chelating drugs. J. Pharmacol. Exp. Ther. 1976, 196, 478-485.